drugset / Trial / NCT04351737

Dextenza for Post-operative Treatment of Pterygium

NCT04351737

Phase 4 Completed 20 enrolled Brandon Eye Associates, PA
NaSingle-groupOpen-labelTreatment

Summary

DEXTENZA for the Treatment of Post-Surgical Pain and Inflammation Compared to Standard of Care Topical Cortico-steroid Treatment in Patients who Undergo Bilateral Pterygium Surgery

Timeline

Start
2020-07-15
Primary completion
2022-07-15
Completion
2023-05-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 0.4 mg Other
Subject Prednisolone Other / unclassified Topical

Indications